Jpmorgan Chase & CO Sanara Med Tech Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,058 shares of SMTI stock, worth $136,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,058
Previous 1,786
127.21%
Holding current value
$136,673
Previous $50,000
144.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SMTI
# of Institutions
43Shares Held
812KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$6.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA173KShares$5.83 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA88.3KShares$2.97 Million0.0% of portfolio
-
State Street Corp Boston, MA58.7KShares$1.98 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.5KShares$1.36 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $280M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...